Dafodil Tri-Leaflet Stented Bioprosthetic Mitral Valve

The Dafodil tri-leaflet design aims to optimize EOA and minimize transvalvular pressure gradients. Hemodynamic stability is further enhanced by the valve's consistent and predictable coaptation, reducing the risk of paravalvular leaks and ensuring effective cardiac output.

The Elgiloy alloy offers superior fatigue resistance and structural integrity, minimizing the risk of stent fracture. The Anti Ca™ proprietary treatment mitigates calcium buildup on the bovine pericardial leaflets, enhancing the valve's long-term durability and reducing the potential for structural valve deterioration.

The Dafodil mitral valve bioprosthesis facilitates ease of implantation with its design. The radiopaque marker enables clear visualization under fluoroscopy, aiding in precise positioning and deployment within the mitral annulus.

This product is manufactured by Meril Life Sciences and is distributed by Agile Healthcare across all districts of Telangana.

Yes, all Meril Life Sciences products distributed by Agile Healthcare, including the Dafodil Tri-Leaflet Stented Bioprosthetic Mitral Valve, strictly adhere to CDSCO guidelines and ISO 13485:2016 quality standards.

The Dafodil Tri-Leaflet Stented Bioprosthetic Mitral Valve is constructed using Bovine pericardium, ensuring high biocompatibility and durability.